Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 5132 vs ISIS 3521 in Metastatic Breast Cancer
NCT00003236Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 1998
- Primary completion
- Jun 2002
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 2 trial of isis 5132, aprinocarsen in breast cancer, sponsored by Eastern Cooperative Oncology Group. Started Jul 1998; status: completed.
02
Drugs
isis 5132aprinocarsen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003236.